Lannett Company Ceo Purchases Stock
Philadelphia, PA – September 12, 2011 – Lannett Company, Inc. (AMEX:LCI), a manufacturer of generic pharmaceuticals, today announced that Arthur Bedrosian, the company’s president and CEO, purchased 20,467 shares of Lannett Company common stock in the open market on September 9, 2011. A Form 4 was filed today reflecting the purchase of the shares.
About Lannett Company, Inc.
Lannett Company, founded in 1942, develops, manufactures, packages, markets and distributes generic pharmaceutical products for a wide range of indications. For more information, visit Lannett Company’s website at www.lannett.com.